JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M411540200 on October 25, 2004

J. Biol. Chem., Vol. 279, Issue 53, 55277-55282, December 31, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/53/55277    most recent
M411540200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimaya, A.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimaya, A.
Right arrow Articles by Roth, R. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

On the Mechanism for Neomycin Reversal of Wortmannin Inhibition of Insulin Stimulation of Glucose Uptake*

Akiyoshi Shimaya, Kristina S. Kovacina, and Richard A. Roth{ddagger}

From the Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305

Although a number of studies and approaches have indicated that activation of the Ser/Thr kinase called Akt/protein kinase B is critical for the insulin-stimulated increase of glucose uptake in adipocytes, other studies have indicated that this enzyme may play an ancillary role. For example, a recent study indicated that neomycin would allow insulin-stimulated Glut4 translocation and glucose transport in the presence of the phosphatidylinositol (PI) 3-kinase inhibitor, wortmannin, a known inhibitor of Akt activation (James, D. J., Salaün, C., Brandie, F. M., Connell, J. M. C., and Chamberlain, L. H. (2004) J. Biol. Chem. 279, 20567–20570). To better understand this observation, we examined a number of downstream targets of Akt. As previously reported, treatment of 3T3-L1 adipocytes with neomycin prevented the wortmannin inhibition of insulin-stimulated glucose transport. However, in the presence of neomycin, wortmannin did not inhibit the insulin-stimulated phosphorylation of several downstream targets of Akt including a proline-rich Akt substrate of 40 kDa, ribosomal protein S6, and glycogen synthase kinase-3. In addition, neomycin did not prevent the ability of a structurally unrelated PI 3-kinase inhibitor, LY294002, to inhibit the insulin-stimulated activation of glucose uptake. Moreover, neomycin reversed the inhibitory effect of wortmannin but not LY294002 on insulin stimulation of Akt kinase activity. Finally, neomycin was found to inactivate in vitro the PI 3-kinase inhibitory actions of wortmannin but not LY294002. These results indicate that the effects of neomycin in adipocytes are not mediated via its ability to sequester phosphatidylinositol 4,5-bisphosphate but are instead caused by the ability of neomycin to inactivate wortmannin.


Received for publication, October 12, 2004

* This work was supported in part by National Institutes of Health Grant DK34976 (to R. A. R.) and Yamanouchi Pharmaceutical (to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Molecular Pharmacology, Stanford University School of Medicine, Rm. 3145B, CCSR, 269 Campus Dr., Stanford, CA 94305-5174. Tel.: 650-723-5933; Fax: 650-723-2253; E-mail: rroth{at}stanford.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
MycologiaHome page
J.-W. Lee, L. V. Roze, and J. E. Linz
Evidence that a wortmannin-sensitive signal transduction pathway regulates aflatoxin biosynthesis
Mycologia, July 1, 2007; 99(4): 562 - 568.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. V. Madhunapantula, A. Sharma, and G. P. Robertson
PRAS40 Deregulates Apoptosis in Malignant Melanoma
Cancer Res., April 15, 2007; 67(8): 3626 - 3636.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. B.M. Nascimento, M. Fodor, G. C.M. van der Zon, I. M. Jazet, A. E. Meinders, P. J. Voshol, R. Vlasblom, B. Baan, J. Eckel, J. A. Maassen, et al.
Insulin-Mediated Phosphorylation of the Proline-Rich Akt Substrate PRAS40 Is Impaired in Insulin Target Tissues of High-Fat Diet-Fed Rats
Diabetes, December 1, 2006; 55(12): 3221 - 3228.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. O. Evans, J. W. Barclay, G. R. Prescott, S.-R. Jo, R. D. Burgoyne, M. J. Birnbaum, and A. Morgan
Protein Kinase B/Akt Is a Novel Cysteine String Protein Kinase That Regulates Exocytosis Release Kinetics and Quantal Size
J. Biol. Chem., January 20, 2006; 281(3): 1564 - 1572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.